RhumbLine Advisers’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$279K Buy
126,799
+2,949
+2% +$6.49K ﹤0.01% 3036
2025
Q1
$144K Sell
123,850
-16,867
-12% -$19.6K ﹤0.01% 3275
2024
Q4
$179K Sell
140,717
-1,158
-0.8% -$1.47K ﹤0.01% 3253
2024
Q3
$484K Buy
141,875
+3,889
+3% +$13.3K ﹤0.01% 2719
2024
Q2
$644K Buy
137,986
+3,862
+3% +$18K ﹤0.01% 2487
2024
Q1
$995K Buy
134,124
+2,738
+2% +$20.3K ﹤0.01% 2248
2023
Q4
$1.33M Sell
131,386
-33
-0% -$334 ﹤0.01% 2117
2023
Q3
$1.03M Buy
131,419
+14,360
+12% +$112K ﹤0.01% 2195
2023
Q2
$963K Buy
117,059
+5,642
+5% +$46.4K ﹤0.01% 2307
2023
Q1
$808K Sell
111,417
-71
-0.1% -$515 ﹤0.01% 2226
2022
Q4
$989K Buy
111,488
+2,881
+3% +$25.6K ﹤0.01% 2133
2022
Q3
$1.33M Buy
108,607
+7,354
+7% +$90K ﹤0.01% 1988
2022
Q2
$1.2M Buy
101,253
+28,708
+40% +$340K ﹤0.01% 2053
2022
Q1
$1.38M Buy
72,545
+576
+0.8% +$11K ﹤0.01% 1994
2021
Q4
$1.91M Sell
71,969
-1,902
-3% -$50.5K ﹤0.01% 1913
2021
Q3
$3.04M Buy
73,871
+1,681
+2% +$69.1K ﹤0.01% 1656
2021
Q2
$4.09M Sell
72,190
-3,217
-4% -$182K 0.01% 1526
2021
Q1
$3.17M Sell
75,407
-4,334
-5% -$182K ﹤0.01% 1661
2020
Q4
$5.59M Buy
79,741
+5,322
+7% +$373K 0.01% 1294
2020
Q3
$2.09M Sell
74,419
-11,847
-14% -$332K ﹤0.01% 1662
2020
Q2
$2.55M Buy
86,266
+12,202
+16% +$361K ﹤0.01% 1591
2020
Q1
$1.47M Buy
74,064
+2,191
+3% +$43.5K ﹤0.01% 1710
2019
Q4
$2.13M Buy
71,873
+6,114
+9% +$181K ﹤0.01% 1770
2019
Q3
$1.5M Sell
65,759
-93
-0.1% -$2.11K ﹤0.01% 1866
2019
Q2
$1.63M Buy
65,852
+5,316
+9% +$132K ﹤0.01% 1852
2019
Q1
$1.48M Sell
60,536
-496
-0.8% -$12.1K ﹤0.01% 1862
2018
Q4
$1.39M Buy
61,032
+20,080
+49% +$457K ﹤0.01% 1853
2018
Q3
$1.3M Sell
40,952
-2,950
-7% -$93.9K ﹤0.01% 1875
2018
Q2
$1.57M Buy
43,902
+9,343
+27% +$335K ﹤0.01% 1804
2018
Q1
$1.15M Buy
34,559
+1,150
+3% +$38.1K ﹤0.01% 1879
2017
Q4
$1.03M Hold
33,409
﹤0.01% 1934
2017
Q3
$802K Buy
33,409
+721
+2% +$17.3K ﹤0.01% 2086
2017
Q2
$549K Buy
+32,688
New +$549K ﹤0.01% 2245